MorphoSys (MOR) News Today €67.25 0.00 (0.00%) (As of 08/20/2024) Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Asymptomatic or Minimally Symptomatic MyelofibrosisNovember 4, 2024 | msn.comBiogen refreshes its C-suite; Novartis writes down MorphoSys assetsOctober 29, 2024 | finance.yahoo.comNovartis says more time needed for cancer therapy added with MorphoSys dealOctober 29, 2024 | msn.comJAK Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 50+ Companies Working in the DomainOctober 22, 2024 | finance.yahoo.comERAS Sep 2024 2.500 put (ERAS240920P00002500)August 28, 2024 | finance.yahoo.comMorphoSys (ETR:MOR) Stock Price Down 0.6%MorphoSys (ETR:MOR) Shares Down 0.6%August 20, 2024 | marketbeat.comMORF Sep 2024 40.000 put (MORF240920P00040000)August 17, 2024 | finance.yahoo.comMorphoSys (ETR:MOR) Hits New 1-Year High at $68.20MorphoSys (ETR:MOR) Reaches New 12-Month High at $68.20May 23, 2024 | marketbeat.comLatest News for MorphoSys Stock (NASDAQ:MOR)May 17, 2024 | benzinga.comMorphoSys gains after Novartis discloses all tender offer conditions were metMay 16, 2024 | msn.comMorphoSys (ETR:MOR) Shares Down 0.1% MorphoSys (ETR:MOR) Trading Down 0.1%May 9, 2024 | marketbeat.comUPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billionMay 2, 2024 | finance.yahoo.comMorphoSys: Hold Rating Until The Novartis Deal ClosesApril 30, 2024 | seekingalpha.comGermany stocks mixed at close of trade; DAX down 0.16%April 29, 2024 | msn.comNew safety risk for MorphoSys drug could complicate Novartis deal - STATApril 28, 2024 | msn.comMorphoSys earnings: here's what Wall Street expectsApril 28, 2024 | markets.businessinsider.comMorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual MeetingApril 24, 2024 | finance.yahoo.comMorphoSys (ETR:MOR) Reaches New 12-Month High at $68.00MorphoSys (ETR:MOR) Reaches New 12-Month High at $68.00April 17, 2024 | marketbeat.comGerman biopharma MorphoSys recommends Novartis offer be acceptedApril 11, 2024 | msn.comNovartis Pharma AG: Novartis tender offer for MorphoSys AG commencesApril 11, 2024 | finanznachrichten.deNovartis tender offer for MorphoSys AG commencesApril 11, 2024 | finance.yahoo.comNovartis begins tender offer for cancer-focused MorphoSysApril 11, 2024 | msn.comNovartis commences tender offer for MorphoSysApril 11, 2024 | msn.comUPDATE 2-Novartis begins tender offer for cancer-focused MorphoSysApril 11, 2024 | finance.yahoo.comNovartis: Higher Guidance, Now A BuyApril 4, 2024 | seekingalpha.comMorphoSys (ETR:MOR) Sets New 52-Week High at $67.30MorphoSys (ETR:MOR) Hits New 52-Week High at $67.30April 2, 2024 | marketbeat.comEQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR ActMarch 22, 2024 | markets.businessinsider.comMorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comEQS-News: MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateMarch 13, 2024 | markets.businessinsider.comMorphoSys: Q4 Earnings InsightsMarch 13, 2024 | benzinga.comGerman regulators approve Novartis deal to buy drugmaker MorphosysMarch 12, 2024 | msn.comWhat Makes MorphoSys AG Unsponsored ADR (MOR) a Strong Momentum Stock: Buy Now?February 15, 2024 | finance.yahoo.comBiotech Stock Roundup: GILD, AMGN & BMY's Q4 Results, MOR Up on NVS Deal & MoreFebruary 8, 2024 | finance.yahoo.comMorphoSys just downgraded at JMP Securities, here's whyFebruary 7, 2024 | realmoney.thestreet.comNovartis (NVS) to Buy MorphoSys & Add Late-Stage Oncology DrugFebruary 6, 2024 | finance.yahoo.comNovartis And MorphoSys Are A Perfect MatchFebruary 6, 2024 | seekingalpha.comNovartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cashFebruary 5, 2024 | finance.yahoo.comUPDATE 1-Novartis to acquire cancer drug developer MorphoSys for $2.9 blnFebruary 5, 2024 | finance.yahoo.comMorphoSys AG ADR MORFebruary 3, 2024 | morningstar.comDAX Edges Higher As Investors Await GDP DataJanuary 31, 2024 | markets.businessinsider.comUS Futures Flat, European Stocks Slightly Down Ahead of Central Bank DecisionsJanuary 30, 2024 | marketwatch.comEuropean Shares Slightly Higher; Flash Eurozone GDP Data AwaitedJanuary 30, 2024 | markets.businessinsider.comMorphoSys expects 2024 Monjuvi U.S. net product sales in $80M - $95M rangeJanuary 30, 2024 | msn.comMorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial LiabilityJanuary 30, 2024 | finance.yahoo.comMorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial LiabilityJanuary 30, 2024 | finance.yahoo.comMorphoSys: Positive Pelabresib Data Finally Unlocking UpsideJanuary 18, 2024 | seekingalpha.comEQS-News: MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceJanuary 8, 2024 | markets.businessinsider.comMorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceJanuary 8, 2024 | finance.yahoo.comOptimistic Investors Push MorphoSys AG (ETR:MOR) Shares Up 48% But Growth Is LackingDecember 18, 2023 | finance.yahoo.comMorphoSys To Issue 3.423 Mln New Shares At EUR 30/shrDecember 14, 2023 | markets.businessinsider.com Get MorphoSys News Delivered to You Automatically Sign up to receive the latest news and ratings for MOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Financial Prophecy (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier. Including the name of the #1 company to buy. MOR Media Mentions By Week MOR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MOR News Sentiment▼0.000.45▲Average Medical News Sentiment MOR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MOR Articles This Week▼01▲MOR Articles Average Week Get MorphoSys News Delivered to You Automatically Sign up to receive the latest news and ratings for MOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ad pepper media International News Today Genfit News Today Merck KGaA News Today Medigene News Today Carl Zeiss Meditec News Today Gerresheimer News Today Evotec News Today CompuGroup Medical SE & Co. KGaA News Today Drägerwerk AG & Co. KGaA News Today Stratec News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MOR) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best n...Resource Stock Digest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MorphoSys AG Please log in to your account or sign up in order to add this asset to your watchlist. Share MorphoSys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
